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ABSTRACT: Providers and patients agree that high-quality care is an essential
component of a high performance health system, a position supported by
The Commonwealth Fund’s Commission on a High Performance Health
System. However, recent debate has focused on how best to define “high qual-
ity” in the hospital setting. Recent journal articles have found only a “modest
relationship” between performance on Hospital Quality Alliance (HQA)
process measures and short-term mortality. Despite the lack of a more robust
connection, the authors of this data brief contend that these HQA measures
represent actionable items that can have an impact on quality and health out-
comes and identify specific activities hospitals can work on to improve per-
formance. Developing new process measures to reduce mortality and other
poor outcomes, while improving performance on the current measures, can
help move the nation toward achieving higher-quality health care and a high
performance health system.
*    *    *    *    *
Introduction
While most providers and patients agree that high-quality care is an essential
component of a high performing health system, there has been much recent
debate regarding how to best define “high quality” in the hospital setting.
Much of the discussion focuses on whether the process measures of the
Hospital Quality Alliance (HQA)—a national public–private collaboration
designed to encourage hospitals to voluntarily collect and report hospital
quality performance information—are valuable.This data brief reviews the
findings of recent studies on the HQA measures, and finds that while addi-
tional quality measures are necessary, providers should not hesitate to take
action to improve performance on the current measures.The Commonwealth
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Fund’s Commission on a High Performance Health
System—launched in 2005 to develop strategies
to promote a health system that provides all
Americans with affordable access to high-quality,
safe care while maximizing efficiency—has identi-
fied high-quality care as one of the core goals of
a high performing health system.1
Since 2005, the Centers for Medicare and
Medicaid Services (CMS) has been publicly
reporting hospital-specific HQA performance
measures on processes of care.These process meas-
ures assess whether certain care processes recom-
mended in clinical guidelines are administered,
such the administration of an aspirin within 24
hours of a heart attack (Table 1). As demonstrated
in the Commission’s national and state scorecards,
there is wide variation on these measures across
the country (Figure 1).2,3
This variation in performance indicates an
opportunity for providers to improve, and also
allows consumers to identify higher- and lower-
performing hospitals. However, the benefit is
dependent on the validity of the measures—that is,
whether they truly reflect quality of care. In con-
trast to mortality rates, which directly measure a
Table 1. Current Hospital Quality
Alliance Process Measures
Heart attack
 Aspirin at arrival
 Aspirin at discharge
 ACE inhibitor or ARB for LVS dysfunction
 Beta blocker at arrival
 Beta blocker at discharge
 Fibrinolytic medication within 30 minutes
of arrival
 PCI received within 90 minutes of
hospital arrival
 Smoking cessation advice/counseling
Heart failure
 Evaluation of LVS function
 ACE inhibitor or ARB for LVS dysfunction
 Discharge instrucctions
 Smoking cessation advice/counseling
Pneumonia
 Oxygenation assessment
 Initial antibiotic timing
 Pneumococcal vaccination
 Influenza vaccination
 Blood culture performed in the emergency
department prior to initial antibiotic
received in hospital
 Appropriate initial antibiotic selection
 Smoking cessation advice/counseling
Surgical care improvement/
surgical infection prevention
 Prophylactic antibiotic received within one
hour prior to surgical incision
 Prophylactic antibiotics discontinued
within 24 hours after surgery end time
 Prophylactic antibiotic selection
Notes: Starter set of 10 measures are italicized.
ACE = angiotensin-converting enzyme; ARB = angiotensin-
receptor blocker; LVS = left ventricular systolic;
PCI = percutaneous coronary intervention.
Source: Centers for Medicare & Medicaid Services Hospital
Compare Web site: http://www.hospitalcompare.hhs.gov.
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vital patient outcome, it is more difficult to tell
whether a process measure is an appropriate meas-
ure of quality of care.
In June 2007, CMS and HQA began pub-
licly reporting hospital performance on 30-day
risk-adjusted mortality for patients admitted for
heart attacks and heart failure, publishing this
information on the Medicare Hospital Compare
Web site (www.hospitalcompare.hhs.gov).The
appeal of mortality rate data is clear: it is easy to
understand that a patient is better off at a hospital
with a low mortality rate than a high one.
However, when CMS separated hospitals into per-
formance categories of:“better than U.S. national
rate” (i.e., better than the national average),“worse
than U.S. national rate,” and “no different than
U.S. national rate,” more than 98 percent of the
hospitals fell into the “no different” category
(Figure 2).
Examining the Hospital Quality Alliance
Process Measures
Although the evidence supporting the individual
care processes captured in the HQA quality meas-
ures is strong, there is a need to evaluate these
measures in the field, as they become widely
adopted for public reporting programs such as
Hospital Compare, as well as for pay-for-perform-
ance programs. Over the past year, there have been
two journal articles that examined the relationship
between the HQA measures and mortality.
The most recent article, written by Ashish
Jha and colleagues and supported by The
Commonwealth Fund, was published in Health
Affairs in July 2007.4 The article compared per-
formance on HQA process measures for heart
attack, heart failure, and pneumonia with risk-
adjusted mortality for those areas.The authors cre-
ated an aggregate performance score for each
condition for each hospital. Examining the full
range of performance by quartiles, their analysis
revealed a consistent relationship of higher per-
formance on the process measures with lower risk-
adjusted mortality (Table 2).
In the Journal of the American Medical
Association, Rachel Werner and Eric Bradlow per-
formed a similar but more limited analysis, also
using the HQA database, with findings consistent
with Jha and colleagues.5 Across all three condi-
tions, the authors found that hospitals performing
in the top quartile on each composite score had
lower risk-adjusted mortality rates than those per-
forming in the lowest quartile.
Two other recent studies examined the rela-
tionship between process measures and patient
outcomes, using measures closely related to the
HQA measures. Elizabeth Bradley and colleagues
examined the relationship between heart attack
process measures from the National Registry of
Myocardial Infarction and mortality, and found
that the measures explained a small proportion of
the variation in mortality.6 Gregg Fonarow and
colleagues examined the relationship between the
American College of Cardiology/American Heart
Association heart failure performance measures
and mortality, and found no relationship with in-
hospital mortality risk for each individual measure.
Only the use of angiotensin-converting enzyme
inhibitor/angiotensin-receptor blocker for left
ventricular systolic dysfunction and beta-blocker
use at discharge were associated with mortality or
rehospitalization at 60 to 90 days.7 Fonorow found
no relationship between other measures, such as
discharge instructions or smoking cessation coun-
seling (both of which are part of the current set of
HQA measures), with the outcomes they studied.
Commentary
Across these studies, it appears that performance
on the initial set of HQA process measures has a
modest relationship to short-term mortality, and
that some individual measures included in the cur-
rent HQA data set are not related to short-term
mortality at all. Some of the more vocal responses
to these findings are troubling, particularly the crit-
icism that since the HQA measures do not have a
large effect on mortality, they also have limited
usefulness for informing consumers about quality of
care, helping providers improve outcomes, or guid-
ing payers seeking value in pay-for-performance
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programs.8 We believe this line of argument is mis-
guided. Instead, we offer the following response:
 Although the relationship between the
HQA measures and mortality is modest and
there are clearly other factors that predict
mortality, the HQA measures represent
actionable items that can have an impact. As
per Jha et al., if hospitals in the lowest quar-
tile of performance had the mortality rates
of the top quartile, approximately 2,200
deaths could have been avoided. Moving all
hospitals to the top decile of performance
would improve this rate substantially. Even
though the measures included in the HQA
do not represent all the process steps that
might reduce mortality, they are an impor-
tant foundation for reductions in mortality.
Although we should continue to search for
additional performance measures, we believe
that these measures should continue to be
used by providers, consumers, and payers.
Table 2. Adjusted Mortality Rates, Stratified by Hospital Performance
on Hospital Quality Alliance (HQA) Summary Scores
Predicted mortality rate (95% confidence interval)
HQA performance AMI CHF Pneumonia
First quartile 10.0% 4.6% 7.1%
(9.7, 10.4) (4.4, 4.8) (6.9, 7.4)
Second quartile 10.2% 4.9% 7.4%
(10.0, 10.5) (4.8, 5.1) (7.2, 7.6)
Third quartile 10.6% 5.0% 7.5%
(10.3, 10.9) (4.8, 5.2) (7.2, 7.7)
Fourth quartile 10.8% 5.0% 7.9%
(10.5, 11.2) (4.8, 5.1) (7.6, 8.1)
p value for trend <0.001 0.005 <0.001
Notes: Adjusted for patient age, sex, race, and the presence or absence of each of 30 comorbidities.
AMI = acute myocardial infarction; CHF = congestive heart failure.
Source: A. K. Jha, E. J. Orav, Z. Li et al.,“The Inverse Relationship Between Mortality Rates and
Performance in the Hospital Quality Alliance Measures,” Health Affairs, July/Aug. 2007 26(4):1104–10.
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 Demonstrating that a process measure has a
relationship to reduction in short-term mor-
tality is desirable, but it not the only criteria
by which we should judge whether it is use-
ful. For instance, Fonarow et al. found no
association between mortality and indicators
that measure whether heart failure patients
received smoking cessation counseling.
However, we would argue that these
processes should nevertheless be performed.
Even minimal counseling (less than three
minutes) by a physician has been shown to
be effective in reducing smoking,9 and
smoking cessation is related to risk reduction
for heart disease, lung cancer, and stroke.10
Decreased mortality is not the only desired
outcome of good medical care. Other
important outcomes for patients and payers
are decreased morbidity, including fewer
in-hospital and post-hospital complications;
fewer rehospitalizations; improved under-
standing of conditions, leading to better
longer-term care and outcomes; and
decreased costs.
Conclusion
Both outcomes measures, such as mortality rates,
and process measures are useful for improving
quality of care.11 Mortality rates may seem to rep-
resent “the bottom line,” but there are numerous
factors, many beyond providers’ control, that con-
tribute to mortality. Risk-adjustment methods to
account for these factors are improving, but as the
recent public reporting effort for heart attack and
heart failure mortality demonstrates, it is difficult
to discriminate among providers using only mor-
tality rates. In addition, mortality rates alone do
not point to the specific actions providers must
undertake to improve care. Process measures
derived from clinical guidelines, such as those in
the HQA, identify specific activities hospitals can
work to improve. Guidance for improving these
processes is available through private entities such
as the Institute for Healthcare Improvement or
through government-sponsored programs such as
Medicare’s Quality Improvement Organizations,
which operate in each state.
The real “bottom line” means not taking a
simplistic approach to measurement and improve-
ment.We must continue to generate evidence to
evaluate new process measures that may help
reduce mortality and other poor outcomes; work
hard to improve performance in the current suite
of HQA measures; and periodically check to
assess the impact of improved implementation of
existing and new measures on outcomes.This
approach will put us well along the path to achieving
higher-quality health care and a high performance
health system.
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